* Aspen Aerogels Inc ASPN.N reported a quarterly adjusted
loss
of 2 cents per share for the quarter ended in March, higher
than the same quarter last year, when the company reported EPS
of -24 cents. The mean expectation of ten analysts for the
quarter was for a loss of 11 cents per share. Wall Street
expected results to range from -17 cents to -2 cents per share.
* Revenue rose 107.3% to $94.50 million from a year ago;
analysts
expected $75.00 million.
* Aspen Aerogels Inc's reported EPS for the quarter was a
loss
of 2 cents.
* The company reported a quarterly loss of $1.84 million.
* Aspen Aerogels Inc shares had fallen by 11.0% this
quarter and
lost 0.8% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 11.8%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the specialty
chemicals
peer group is also "buy"
Wall Street's median 12-month price target for Aspen Aerogels
Inc is $20.00
This summary was machine generated from LSEG data May 2 at 12:19
a.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.11 -0.02 Beat
Dec. 31 2023 -0.12 -0.01 Beat
Sep. 30 2023 -0.27 -0.19 Beat
Jun. 30 2023 -0.36 -0.22 Beat